NovaBay Pharmaceuticals reported a net loss of $2.4 million, or $0.16 per share, for the third quarter of 2017 compared with a net loss of $3.7 million, or $0.34 per share, for the third quarter of 2016.
Net sales for the quarter rose from $3.4 million to $4.1 million, according to a company press release.
Sales and marketing expenses increased from $2.7 million in 2016’s third quarter to $3.3 million in the third quarter of 2017, which was attributed to an increase in the number of sales representatives and increased sampling and marketing programs.
General and administrative costs were
Uncategorized